Commentary: Valve options for ischemic mitral regurgitation in an era of new technologies: ViV(a) la bioprosthetic

[摘要] Bernard and colleagues1 have presented their findings that prosthetic valve selection does not influence long-term survival in patients undergoing mitral valve replacement for ischemic mitral regurgitation; however, bioprosthetic valves appear to be associated with less morbidity. Guidelines on valve selection have generally cited patient age and suitability for lifelong anticoagulation, tempered by patient preference, as the dominant criteria for making recommendations. Evidence can be found to support bioprosthetic as well as mechanical valve use.

[学科分类] 心脏病和心血管学